Collagen Types I, II, III: Complete Purpose-Based Selection Guide

Collagen is the most abundant protein in the human body, constituting approximately 30% of total protein mass and serving as the primary structural component of skin, bone, tendons, cartilage, blood vessels, and gut lining. Yet despite being a single protein family, collagen is not a monolith — the human genome encodes at least 28 distinct collagen types, each with a different molecular structure, tissue distribution, and physiological function. For consumers navigating a supplement market that often uses 'collagen' as an undifferentiated category, understanding which type to select for a specific wellness goal — skin elasticity, joint comfort, or connective tissue support — requires clarity on the biology. This guide provides a complete, purpose-driven breakdown of the three most supplemented types: Type I, Type II, and Type III collagen, with the evidence base for each and practical selection guidance.

Collagen in the Human Body: An Overview

All collagens share a core structural motif: three polypeptide alpha chains wound into a right-handed triple helix, stabilized by the repeating amino acid sequence (Gly-X-Y)n, where glycine occupies every third position (the only amino acid small enough to fit inside the triple helix core) and X and Y are frequently proline and hydroxyproline, respectively. Hydroxyproline is uniquely dependent on vitamin C for its synthesis — which is why scurvy manifests as collagen degradation, and why vitamin C is essential to any collagen-supporting nutrition strategy.

Collagen synthesis declines with age at approximately 1% per year after age 25, with accelerated loss driven by UV radiation, chronic stress (elevated cortisol suppresses fibroblast collagen output), smoking, and diets high in advanced glycation end products (AGEs). By age 40, the cumulative reduction in dermal collagen is functionally significant — driving skin laxity, reduced joint cartilage thickness, and bone density changes.

Dietary collagen enters the digestive system as intact protein and is broken down by proteases into individual amino acids and small peptides. The historically dominant view was that these would be non-specifically incorporated into the body's general amino acid pool. However, clinical evidence over the past decade demonstrates that specific collagen-derived peptides (particularly hydroxyproline-proline dipeptides) are absorbed intact, circulate in the bloodstream, and can stimulate fibroblast and chondrocyte collagen synthesis directly — a mechanism that explains why type-specific collagen peptide supplementation produces tissue-specific effects.

Type I Collagen: Skin, Bone, and Tendon

Type I collagen is the predominant collagen in the human body, constituting more than 90% of the body's collagen mass. It is the primary structural protein of the dermis, bone cortex, tendons, ligaments, cornea, and dentin. In the dermis specifically, Type I collagen fibers form a dense, organized mesh in the reticular dermis that provides the skin's tensile strength — the resistance to stretching and tearing.

Structurally, Type I collagen is a heterotrimer composed of two alpha-1 chains and one alpha-2 chain. Its fibers are organized into large bundles (fibrils → fascicles → fibers) that align with the dominant directional stress in each tissue — parallel to the long axis in tendons, woven in multiple directions in skin to resist omnidirectional forces.

Primary sources for supplementation:

• Marine collagen (fish skin and scales) — composed predominantly of Type I; high in the hydroxyproline-proline peptides most studied for skin benefits
• Bovine hide collagen — rich in Type I and Type III (discussed below)
• Eggshell membrane — a mixed Type I, V, and X source

Best for: Skin elasticity and hydration, bone density support, tendon and ligament tissue, anti-aging skin goals.

Type II Collagen: Cartilage and Joint Health

Type II collagen is the dominant collagen of hyaline cartilage, constituting approximately 80–85% of cartilage dry weight. Unlike the dense, highly organized fibrils of Type I, Type II collagen forms a fine fibrillar network that interacts with aggrecan proteoglycans to create the compressive load-bearing capacity of articular cartilage. It is specifically found in articular cartilage (joint surfaces), intervertebral discs, the vitreous humor of the eye, and the growth plates of developing bone.

Type II collagen supplementation works through a mechanism distinct from simple amino acid provision: in a process termed oral tolerance, undenatured (native) Type II collagen peptides interact with Peyer's patches in the small intestine, inducing regulatory T cells (Tregs) that suppress the autoimmune-like inflammatory attack on joint cartilage that characterizes conditions like age-related joint wear. This is the immunological mechanism behind the small daily dose (10–40 mg) used in native Type II collagen products — a dose far lower than the 5–10 g used for hydrolyzed Type I and III products.

Primary sources:

• Chicken sternum cartilage (UC-II — undenatured Type II collagen) — most studied for joint comfort outcomes
• Bovine tracheal cartilage
• Shark cartilage (less preferred due to sustainability concerns)

Best for: Joint comfort support, cartilage wellness, articular surface maintenance, active adults with joint awareness.

Type III Collagen: Soft Tissue and Gut Structure

Type III collagen is a homotrimer (three identical alpha-1(III) chains) and is typically co-distributed with Type I collagen in soft connective tissues — skin, blood vessel walls, intestinal submucosa, uterus, and liver. It is the dominant collagen in early wound healing and embryonic tissue, where its thinner, more pliable fibers provide structural support in rapidly remodeling tissue. As wounds mature, Type III is gradually replaced by Type I collagen in the remodeling phase.

In the skin, Type III collagen is most concentrated in the papillary dermis (the upper dermis near the basement membrane), where it forms a fine fibrillar network that supports epidermal-dermal adhesion and gives young skin its characteristic softness and flexibility. With aging, the ratio of Type I to Type III shifts — Type III content in skin declines proportionally more than Type I, contributing to the loss of youthful skin texture.

In the gut, Type III collagen in the submucosa provides structural support for intestinal integrity, and gut-focused collagen products often emphasize their Type III content alongside glycine — the most abundant amino acid in collagen and a key nutrient for enterocyte function and gut barrier integrity.

Primary sources:

• Bovine hide collagen — delivers Type I and III together in naturally co-occurring ratios
• Bone broth — a dietary source of mixed collagen peptides including Type I and III

Best for: Skin softness and texture, gut lining support, early wound tissue remodeling, cardiovascular tissue wellness.

Side-by-Side Comparison and Selection Guide

Most commercial 'collagen peptide' products labeled as 'hydrolyzed collagen' or 'collagen powder' are bovine hide or marine-sourced and deliver a mixture predominantly of Type I and Type III. Products specifically marketed for joint health typically specify their UC-II (undenatured Type II) content. If your primary goal is skin and general connective tissue support, a standard hydrolyzed marine or bovine product at 5–10 g/day is appropriate. If joint cartilage is the primary concern, look specifically for products standardized to UC-II at 40 mg/day.

Supplementation Evidence and Dosing

The clinical evidence for collagen supplementation has matured considerably over the past decade, particularly for skin and joint outcomes:

Type I/III for skin: A 2014 double-blind, placebo-controlled trial by Proksch et al. (Skin Pharmacology and Physiology) found that 2.5 g/day of specific bioactive collagen peptides (VERISOL) over 8 weeks significantly improved skin elasticity (measurable reduction in the ratio of elastic recovery to total deformation), with effects maintained at 4-week post-trial follow-up. A 5 g dose produced statistically greater collagen density improvement. A 2015 follow-up by the same group found 2.5 g/day over 24 weeks reduced periorbital wrinkle depth by 20% versus placebo.

Type II for joints: A 2009 study by Crowley et al. (International Journal of Medical Sciences) found that 40 mg/day of UC-II produced significantly greater improvements in joint comfort and function over 90 days compared to 1500 mg glucosamine + 1200 mg chondroitin — the then-standard joint supplement combination. UC-II's oral tolerance mechanism appears to be dose-saturable, explaining why higher doses do not necessarily outperform the 40 mg amount.

Important cofactors: Collagen synthesis is enzymatically dependent on vitamin C (required for prolyl hydroxylase and lysyl hydroxylase that cross-link the triple helix), zinc (cofactor for procollagen protease), and copper (required for lysyl oxidase, which cross-links mature collagen fibers). Supplements providing collagen peptides without these cofactors leave the cellular machinery for collagen assembly under-resourced. A target intake of 500–1000 mg vitamin C daily alongside collagen supplementation is well-supported by the biochemistry.

NIR LED and Collagen Synthesis: A Complementary Strategy

The relationship between NIR photobiomodulation and collagen production is directly relevant to any collagen supplementation strategy. Collagen peptide supplementation works by providing hydroxyproline-proline peptides that reach fibroblasts as bioactive signals — upregulating the fibroblast's internal collagen synthesis machinery. NIR LED at 660 nm targets the same fibroblast through a different pathway: photon absorption by cytochrome c oxidase increases ATP production, providing the cellular energy substrate that the collagen synthesis process itself requires.

The combination is physiologically complementary: supplementation provides the stimulating signal and the amino acid building blocks; NIR provides the cellular energy to act on those signals effectively. A 2005 study by Weiss et al. (Journal of Clinical and Aesthetic Dermatology) demonstrated measurable increases in Type I and III collagen mRNA expression in dermal fibroblasts exposed to red light at 3–6 J/cm², with peak response at 660 nm. These gene expression changes precede measurable collagen protein deposition by 1–4 weeks — consistent with the timeline observed in clinical collagen supplementation trials.

The combined strategy — collagen peptide supplementation at 5–10 g/day (Type I/III for skin goals) alongside daily NIR LED application at 3–8 J/cm² — provides complementary inputs to dermal fibroblast collagen output. The nutritional approach ensures substrate availability; the photobiomodulatory approach ensures the cellular machinery is optimally energized to use those substrates.

Safety, Quality, and Practical Guidance

Product quality considerations:

• Look for third-party tested products (NSF Certified for Sport, Informed Sport, or USP verified) to ensure the stated collagen type and dose is accurately labeled and free of contaminants.
• Marine collagen products should specify the fish species and whether they are sustainably sourced. Heavy metal testing is particularly important for marine-derived supplements.
• For UC-II (Type II), look for products standardized to 40 mg UC-II per serving, as this is the clinically studied dose. Higher doses have not demonstrated proportionally greater benefit.

Timing and absorption: Collagen peptides are generally stable and can be consumed at any time of day. Some practitioners recommend consuming them approximately 30–60 minutes before exercise — the exercise-induced increase in blood flow to connective tissue may enhance collagen peptide delivery to the target tissues during the post-exercise synthesis window. Vitamin C cofactor should be consumed at the same time.

Potential allergens: Marine collagen is contraindicated in individuals with shellfish or fish allergies. Bovine collagen is not appropriate for those with bovine protein sensitivities or who avoid animal products. Hydrolyzed collagen from any source is typically well-tolerated, but new users should start with a smaller dose (1–2 g/day) and increase over 1–2 weeks to assess tolerance.

CIRIUS as a wellness complement, not a treatment: The CIRIUS NIR LED device is a home wellness device for supporting collagen-related skin and tissue wellness routines. It is not a medical device for treating collagen-related diseases or conditions. Consult a registered dietitian or healthcare provider for personalized guidance on collagen supplementation in the context of specific health goals.